Development Level

Tbio 134 | 11,651
Tchem 11 | 1,388
Tclin 4 | 612
Tdark 1 | 6,593

IMPC Phenotype

embryonic lethality prior to o... 2 | 239
embryonic lethality prior to t... 2 | 278
increased neutrophil cell numb... 2 | 46
abnormal anxiety-related respo... 1 | 1
abnormal embryo size 1 | 220
abnormal gait 1 | 69
abnormal heart morphology 1 | 162
abnormal lens morphology 1 | 81
abnormal lung morphology 1 | 26
abnormal seminal vesicle morph... 1 | 114
abnormal skin morphology 1 | 50
abnormal sleep behavior 1 | 70
abnormal social-conspecific in... 1 | 3
cataract 1 | 92
decreased body weight 1 | 161
decreased bone mineral content 1 | 151
decreased erythrocyte cell num... 1 | 62
decreased heart left ventricle... 1 | 28
decreased hematocrit 1 | 46
decreased hemoglobin content 1 | 68
decreased lymphocyte cell numb... 1 | 83
decreased mature B cell number 1 | 7
decreased mean corpuscular vol... 1 | 79
decreased threshold for audito... 1 | 26
embryonic growth retardation 1 | 106
enlarged heart 1 | 210
enlarged lymph nodes 1 | 37
hydrometra 1 | 53
impaired righting response 1 | 26
increased circulating chloride... 1 | 41
increased circulating sodium l... 1 | 71
increased erythrocyte cell num... 1 | 39
increased exploration in new e... 1 | 8
increased lymphocyte cell numb... 1 | 32
increased mean corpuscular hem... 1 | 96
increased mean corpuscular vol... 1 | 92
increased monocyte cell number 1 | 63
increased prepulse inhibition 1 | 32
preweaning lethality, incomple... 1 | 499
prolonged PR interval 1 | 15
small superior vagus ganglion 1 | 74
thrombocytopenia 1 | 56

Disease

Cancer 95 | 2,499
psoriasis 84 | 6,694
diabetes mellitus 79 | 1,728
Carcinoma 76 | 11,493
Hypersensitivity reaction type II disease 72 | 253
Ankylosing spondylitis 71 | 140
Behcet's disease 70 | 89
Rheumatoid arthritis 66 | 1,191
Arthritis 65 | 290
Juvenile rheumatoid arthritis 63 | 111
Acquired immunodeficiency syndrome 60 | 197
Uveitis 60 | 103
Herpes zoster 57 | 68
dermatomyositis 55 | 966
Human immunodeficiency virus infectious disease 54 | 138
Psoriatic arthritis 52 | 86
Stevens-Johnson syndrome 52 | 92
Multiple Sclerosis 49 | 540
tuberculosis 42 | 2,010
Dermatitis 40 | 157
ovarian cancer 40 | 8,520
glioblastoma 39 | 5,792
lung cancer 37 | 4,740
osteosarcoma 37 | 7,950
Synovitis 36 | 78
Behcet's syndrome 35 | 50
Congenital adrenal hyperplasia 35 | 73
Nephritis 35 | 51
Retinal vasculitis 35 | 36
Spondyloarthropathy, Susceptibility To, 1 35 | 35
Takayasu's arteritis 35 | 53
drug-induced hepatitis 35 | 44
lung carcinoma 34 | 2,843
juvenile dermatomyositis 31 | 1,187
Astrocytoma, Pilocytic 29 | 3,081
Hepatitis B 28 | 108
Liver disease 28 | 237
Anemia 27 | 365
Kidney disease 27 | 430
adult high grade glioma 26 | 3,801
cutaneous lupus erythematosus 26 | 1,057
Leprosy 25 | 73
subependymal giant cell astrocytoma 25 | 2,287
Hemochromatosis 23 | 54
Primary immunodeficiency disease 23 | 54
Skin disease 23 | 66
Systemic lupus erythematosus 23 | 194
ependymoma 23 | 4,679
intraductal papillary-mucinous neoplasm (IPMN) 22 | 3,291
Birdshot chorioretinopathy 21 | 23
interstitial cystitis 21 | 2,312
malignant mesothelioma 21 | 3,232
invasive ductal carcinoma 20 | 2,951
primary Sjogren syndrome 20 | 735
intraductal papillary-mucinous carcinoma (IPMC) 19 | 2,989
medulloblastoma, large-cell 19 | 6,241
pancreatic cancer 19 | 2,398
sarcoidosis 19 | 370
intraductal papillary-mucinous adenoma (IPMA) 18 | 2,955
Narcolepsy 17 | 72
atypical teratoid / rhabdoid tumor 17 | 5,112
ulcerative colitis 17 | 1,819
active Crohn's disease 16 | 922
active ulcerative colitis 16 | 764
cystic fibrosis 16 | 1,696
Berylliosis 15 | 28
Breast cancer 15 | 3,578
Human immunodeficiency virus type 1, susceptibility to 15 | 26
Pre-Eclampsia 15 | 68
Schizophrenia 15 | 1,160
astrocytoma 15 | 1,146
breast carcinoma 15 | 1,638
non-small cell lung cancer 15 | 2,890
Diffuse cutaneous systemic sclerosis 14 | 17
Multiple Sclerosis, Susceptibility to 14 | 15
Narcolepsy-cataplexy 14 | 21
Psoriasis susceptibility 1 14 | 14
limited scleroderma 14 | 19
pituitary cancer 14 | 1,972
Rheumatoid Arthritis, Systemic Juvenile 13 | 16
Sarcoidosis 1 13 | 14
esophageal adenocarcinoma 13 | 737
follicular lymphoma 13 | 20
Liver Cirrhosis, Experimental 12 | 769
pancreatic ductal adenocarcinoma liver metastasis 12 | 1,962
Influenza 11 | 142
Multiple myeloma 11 | 1,332
Duchenne muscular dystrophy 10 | 601
Asthma 9 | 385
Autosomal recessive predisposition 9 | 1,442
Bipolar Disorder 9 | 666
Microphthalmia with limb anomalies 9 | 40
Vasculitis 9 | 80
group 3 medulloblastoma 9 | 4,104
lung adenocarcinoma 9 | 2,716
Arthritis, Rheumatoid 8 | 174
Atopic dermatitis 8 | 952
Crohn's disease 8 | 321
Influenza, Human 8 | 51
ductal carcinoma in situ 8 | 1,745

Tissue

Liver and Pancreas 66 | 16,750
Digestive Tract 65 | 17,369
Endocrine System 65 | 18,159
Female tissues 65 | 17,400
Respiratory system 65 | 16,393
Skin and soft tissues 65 | 17,230
Blood and immune system 64 | 16,909
Urinary Tract 64 | 16,678
Male tissues 63 | 17,142
Cardiovascular System 62 | 15,192
Nervous System 62 | 16,725

Target Family

Non-IDG 116 | 12,091
Enzyme 14 | 4,145
Transcription Factor 10 | 1,400
Kinase 8 | 634
GPCR 1 | 408
TF/Epigenetic 1 | 38

GO Process

interferon-gamma-mediated sign... 150 | 150
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
HLA class I histocompatibility antigen, A-25 alpha chain HLA-A Tbio Non-IDG -2.41667 4123.8 0
HLA class I histocompatibility antigen, B-51 alpha chain HLA-B Tbio Non-IDG -1.88752 1613.5 0
HLA class I histocompatibility antigen, B-37 alpha chain HLA-B Tbio Non-IDG -1.88752 1613.5 0
Interferon gamma receptor 1 IFNGR1 Tbio Non-IDG -2.23009 172.7 518
HLA class I histocompatibility antigen, alpha chain G HLA-G Tbio Non-IDG -3.09525 1317.6 913
Interferon gamma receptor 2 IFNGR2 Tbio Non-IDG -1.70048 44.2 264
Neural cell adhesion molecule 1 NCAM1 Tbio Non-IDG -3.58910 3930.7 1982
HLA class I histocompatibility antigen, B-57 alpha chain HLA-B Tbio Non-IDG -1.88752 1613.5 0
Interferon regulatory factor 2 IRF2 Tbio Transcription Factor -2.15319 132.7 378
HLA class I histocompatibility antigen, A-3 alpha chain HLA-A Tbio Non-IDG -2.41667 4123.8 686